Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide-Reference-Cited by-同舟云学术

Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide

Published:2012 Issue:5 Volume:18 Page:753-755
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Uemura Keiichiro,Nishihara Kiyoaki,Hayashi Tokumasa,Tomiyasu Katsuro,Matsuoka Kei

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://www.springerlink.com/index/pdf/10.1007/s10156-011-0352-9

Reference14 articles.

1. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that has relapsed after initial maximum androgen blockade;Suzuki;J Urol,2008

2. Low dose of oral dexamethasone for hormone-refractory prostate carcinoma;Nishimura;Cancer,2000

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Eng J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Eng J Med,2004

5. Chemotherapy for endocrine resistant cancer for the prostate;Eisenberger;Prog Clin Biol Res,1990

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional Delivery of Anti-PD-1 Agent for Colorectal Liver Metastases Improves Therapeutic Index and Anti-Tumor Activity;Vaccines;2021-07-21

2. Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction;Drug Discovery Today;2014-12

3. A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report;Oncology Letters;2013-01-15